Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 7 (of 7 Records)

Query Trace: Syndrome and CDA[original query]
Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity.
British journal of cancer 2013 Jun 108 (12): 2505-15.
Loganayagam A, Arenas Hernandez M, Corrigan A, Fairbanks L, Lewis C M, Harper P, Maisey N, Ross P, Sanderson J D, Marinaki A
Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer.
Pharmacological research 2017 Aug .
Lam Siu W, van der Noort Vincent, van der Straaten Tahar, Honkoop Aafke H, Peters Godefridus J, Guchelaar Henk-Jan, Boven Ep
Novel Genetic Variants in Carboxylesterase 1 Predict Severe Early-Onset Capecitabine-Related Toxicity.
Clinical pharmacology and therapeutics 2017 Nov 102 (5): 796-804.
Hamzic S, Kummer D, Milesi S, Mueller D, Joerger M, Aebi S, Amstutz U, Largiader C
CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine.
Blood advances 2018 Mar 2 (5): 462-469.
Fanciullino Raphaelle, Farnault Laure, Donnette Mélanie, Imbs Diane-Charlotte, Roche Catherine, Venton Geoffroy, Berda-Haddad Yael, Ivanov Vadim, Ciccolini Joseph, Ouafik L'Houcine, Lacarelle Bruno, Costello Reg
Determinants of the interindividual variability in serum cytidine deaminase activity of patients with solid tumours.
British journal of clinical pharmacology 2018 Dec .
Cohen R, Preta L H, Joste V, Curis E, Huillard O, Jouinot A, Narjoz C, Thomas-Schoemann A, Bellesoeur A, Tiako Meyo M, Quilichini J, Desaulle D, Nicolis I, Cessot A, Vidal M, Goldwasser F, Alexandre J, Blanchet
Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients.
Pharmaceutics 2023 11 15 (11): .
Yasmin Cura, Almudena Sánchez-Martín, Noelia Márquez-Pete, Encarnación González-Flores, Fernando Martínez-Martínez, Cristina Pérez-Ramírez, Alberto Jiménez-Moral
Capecitabine-induced hand-foot syndrome: A pharmacogenetic study beyond DPYD.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 1 159 114232.
de With Mirjam, van Doorn Leni, Maasland Demi C, Mulder Tessa A M, Oomen-de Hoop Esther, Mostert Bianca, Homs Marjolein Y V, El Bouazzaoui Samira, Mathijssen Ron H J, van Schaik Ron H N, Bins Sand
TOP